Nanjing Immunophage Biomedical Co., Ltd.
PrivateLast Round
Series B
Mar 13, 2023
Total Funding Raised
$89.9M
Company Overview
Nanjing Immunophage Biomedical Co., Ltd. is a biotechnology company that researches and develops innovative medicines for the treatment of cancer, autoimmune diseases, and neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Immunophage Biomedical Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nanjing Immunophage Biomedical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 13, 2023 | ||||
| Series A Extension | Sep 29, 2021 | ||||
| Series A | May 11, 2021 | ||||
| Pre Seed | May 1, 2020 | ||||
| Strategic | Oct 31, 2019 |
Nanjing Immunophage Biomedical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series B |
| FountainBridge Capital | Series A Extension |
| Daoyuan Capital | Series A Extension |
| Yijing Capital | Series A Extension |
| Ennovation Ventures | Strategic |
Nanjing Immunophage Biomedical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanjing Immunophage Biomedical Co., Ltd.'s valuation, stock price, and market status.